Offspring of diabetic mothers are susceptible to the onset of metabolic syndromes, such as type 2 diabetes and obesity at adulthood, and this trend can be inherited between generations. Genetics cannot fully explain how the noncommunicable disease in offspring of diabetic mothers is caused and inherited by the next generations. Many studies have confirmed that epigenetics may be crucial for the detrimental effects on offspring exposed to the hyperglycemic environment. Although the adverse effects on epigenetics in offspring of diabetic mothers may be the result of the poor intrauterine environment, epigenetic modifications in oocytes of diabetic mothers are also affected. Therefore, the present review is focused on the epigenetic alterations in oocytes and embryos of diabetic mothers. Furthermore, we also discuss initial mechanistic insight on maternal diabetes mellitus causing alterations of epigenetic modifications.
INTRODUCTION
Diabetes mellitus is a chronic disease characterized by elevated blood glucose levels, impaired insulin secretion, and/ or peripheral resistance to insulin action. As of 2012, more than 371 million people were reported to have diabetes mellitus, and most of them were distributed throughout the developing countries, such as China and India [1] . Not only does diabetes mellitus cause many complications for patients, but their offspring have a higher risk of malformations [2] . Furthermore, maternal diabetes mellitus can affect the offspring's health by increasing the risk for some noncommunicable disorders in adulthood [3] [4] [5] . A large number of epidemiologic studies revealed that infants of diabetic mothers are more susceptible to complex diseases, such as obesity [6] , type 2 diabetes [7] , cardiovascular complications [8] , and even cancer [9] . Although preexisting insulin-dependent diabetes mellitus in women can be well controlled, these women still experience a three-to fivefold higher incidence of pregnancy complications [10, 11] . The risk for non-communicable diseases may be caused by epigenetic variations because genetics explains only a small proportion of the effects [12, 13] . The ''Barker hypothesis,'' stating that undernutrition before birth induces persisting changes in a range of metabolic, physiological, and structural parameters, may explain this phenomenon very well [13] .
Furthermore, maternal diabetes mellitus injures ovarian function and oogenesis [14] ; developmental anomalies induced by maternal diabetes mellitus are also found in the embryo and fetus [15, 16] . These data indicate that the early environmental exposure to maternal diabetes may be a key reason for the offspring's impaired health in adulthood. Epigenetics provides a link between genes and the environment, and epigenetic alterations can be inherited by the next generation. Therefore, this review is focused on the epigenetic changes in oocytes and embryos of diabetic mothers and on discussing the relationship between maternal hyperglycemia and epigenetic changes in oocytes and embryos.
EPIGENETICS AND OFFSPRING OF DIABETIC MOTHERS
Early in the 1990s, Dörner and Plagemann showed that exposure to a hyperglycemic intrauterine environment increases the risk of obesity and diabetes in offspring [17] ; similar conclusions were reported in a large number of epidemiological studies, indicating that children exposed to a diabetic intrauterine environment have an increased risk of developing obesity, type 2 diabetes mellitus, and metabolic syndrome, among other chronic diseases, later in life [9, [18] [19] [20] [21] . However, the mechanism(s) underlying the increased risk of obesity and diabetes in offspring of diabetic mothers are not well understood.
Epigenetics and Candidate Genes
Epigenetic modifications are generally assumed to mediate gene-environment interactions, leading to persistent changes of gene regulation and metabolic pathways [22, 23] . Studies indicate that changes in DNA methylation of specific sequences, one of the most stable and best understood epigenetic modifications [24] , may result in obesity and diabetes mellitus [25, 26] (Table 1) . When glucose tolerance is impaired during gestation, DNA methylation levels in the leptin gene promoter are altered in placentas, resulting in a reduction of its expression [27] . Mice derived from streptozotocin (STZ)-induced diabetic dams showed impairments in metabolic regulation that were associated with leptin resistance during adulthood. Furthermore, the ability of leptin to activate intracellular signaling in arcuate neurons was also significantly reduced in neonates born to diabetic dams [28] . Recently, Ding et al. [29] found that the methylation status of the differentially methylated regions of H19 and Igf2 was altered in islets of F1 and F2 offspring from gestational diabetes mellitus and that their expressions were also down-regulated in the STZ-induced mice model.
Another study showed that DNA methylation in the promoter of the adiponectin gene on the fetal side of the placenta is inversely correlated with maternal glucose levels during the second trimester of pregnancy [30] . El Hajj et al. [31] analyzed the DNA methylation patterns of several genes in placental tissues and cord blood from 88 newborns of mothers with dietetically treated gestational diabetes mellitus, 98 with insulin-dependent gestational diabetes mellitus, and 65 without gestational diabetes mellitus. The results showed that the methylation level of the maternally imprinted MEST gene, nonimprinted glucocorticoid receptor NR3C1, and interspersed ALU repeats was decreased in gestational diabetes mellitus in both analyzed samples when compared with controls. The different blood MEST methylation was also observed in morbid obese adults compared with normal-weight controls. Further studies showed that the DNA methylation levels of ATP-binding cassette transporter A1 in cord blood and placental tissues were associated with glucose and cord blood triglyceride levels [32] . These independent studies all indicate that epigenetic changes could contribute to explaining the detrimental health effects associated with fetal programming, such as increased risk of obesity and type 2 diabetes mellitus in offspring of diabetic mothers.
Epigenetics and Genome-Wide Methylation
To investigate the whole DNA methylation status of tissues from offspring exposed to maternal diabetes, Li et al. [33] utilized a mouse model to evaluate the cytosine methylation levels in livers from offspring of obese and diabetic mothers. The results showed that although gene expression was widely affected, there were subtle alterations in cytosine methylation. However, Nomura et al. [34] showed in patients with gestational diabetes that the global methylation levels in the placenta were lower compared with patients without gestational diabetes. They suggest that the abnormal global methylation level in the placenta is associated with an abnormal infant body length and head circumference. Similar results in offspring from diabetic mothers were reported in another study; the methylation status at more than 485 000 CpG sites was analyzed in the placenta and umbilical blood of offspring exposed to gestational diabetes mellitus. The results indicated that 3271 and 3758 genes in the placenta and cord blood, respectively, were potentially differentially methylated between samples either exposed or not exposed to gestational diabetes mellitus and that more than 25% of the genes were common to both samples. Eleven percent of the genes were likely involved in the metabolic disease pathways [35] . To identify the candidate genes and biological pathways associated with differentially methylated regions in relation to exposure to gestational diabetes mellitus, West et al. [36] investigated the DNA methylation patterns at more than 27 000 CpG sites of peripheral blood from offspring, ranging from 8 to 12 yr of age, either exposed or not exposed to the diabetic environment during pregnancy. They identified some variations in genome-wide DNA methylation patterns resulting from intrauterine exposure to maternal gestational diabetes mellitus, and many of them were linked to metabolic diseases in the offspring of diabetic mothers. These studies indicate that epigenetic changes may play a key role in the detrimental effects on offspring of diabetic mothers.
EPIGENETICS AND EMBRYOS OF DIABETIC FEMALES
While previous studies indicated that epigenetic modifications in offspring of diabetic mothers occur, the detailed underlying mechanisms are still unclear. As epigenetics can be affected during the neonatal period, the Barker hypothesis established that the adverse intrauterine environment may be an important factor for the risk of diseases in offspring [13] . In humans and animal models, if nutrient intake is imbalanced during pregnancy, fetal growth is restricted, increasing the exposed offspring's susceptibility to insulin resistance, diabetes, and obesity later in life [37] [38] [39] . These disease risks in offspring may be associated with epigenetic changes. In the nutrient-restricted model, epigenetic modifications including DNA methylation and histone modification are changed in many tissues of the fetus [40] . The epigenetic modifications in offspring of diabetic mothers are also altered (Table 1 ). In the streptozotocin-induced mouse model, the mRNA expression of Igf2 and the methylation level of the H19-Igf2 imprint control region were changed in fetuses on Embryonic Day 14 GE ET AL.
compared with control dams [41] . In our laboratory, we investigated the DNA methylation patterns in differentially methylated regions of imprinted Peg3, Snrpn, and H19 in fetuses and placental tissues on Day Postcoitum (dpc) 10.5 utilizing the streptozotocin-induced mouse model [42] . We found that the methylation status of Peg3, Snrpn, and H19 in dpc-10.5 fetuses was not altered by the diabetic intrauterine environment but that the methylation patterns of Peg3 and H19 were changed in the dpc-10.5 placentas. The changes of mRNA expression of Peg3 in dpc-10.5 placentas in the groups coincided with the DNA methylation patterns. The histone modifications in the offspring from diabetic females have also been found to be altered. Salbaum and Kappen [43] observed that maternal diabetes and exposure to a high-fat diet caused alterations in H3 and H4 histone acetylation in the embryos. Changes of H3K27 acetylation marks were significantly enriched near genes known to cause neural tube defects in mouse E8.5 embryos from diabetic mothers. These results for embryos from diabetic pregnancies support the notion that maternal diabetic distress, as brought about by hyperglycemia, alters patterns of histone modification across the genome [44] .
Although these data provide molecular evidence to support the changes of epigenetics evoked by the adverse intrauterine environment, how the diabetic intrauterine environment causes epigenetic alterations remains unanswered. Jimenez-Chillaron et al. [45] and Stoffers et al. [46] indicate that there are critical periods of developmental plasticity during which nutritional and pharmacological interventions can reverse abnormal metabolic functions and reduce the risk of adulthood disease. Smith et al. [47] suggest that preimplantation development is a unique developmental period where methylation is differentially positioned and regulated before being restored and maintained in a somatic fashion. This indicates that this period is a key window for establishing the somatic DNA methylation patterns. However, studies have confirmed that the metabolism of early embryos is affected by maternal hyperglycemia. In the in vivo mouse model, maternal hyperglycemia down-regulated the embryonic facilitative glucose transporters 1, 2, and 3 at the blastocyst stage of development [48] ; in vitro studies in which two-cell embryos were cultured for 72 h in high concentrations of glucose (30 or 52 mM) also resulted in decreased mRNA and protein expressions of the facilitative transporters [48] [49] [50] . Therefore, the utilization of glucose was also affected in early embryos of diabetic mothers. Glucose availability can affect histone acetylation in an adenosine triphosphate-citrate lysase (ACL)-dependent manner [51] . ACL is required for increases in histone acetylation in response to growth factor stimulation and during differentiation, and histone acetylation can be affected by glucose availability. These data indicate that abnormal glucose metabolism may play a key role in the alterations of epigenetics in embryos.
EPIGENETICS AND OOCYTES OF DIABETIC MOTHERS
The intrauterine environment has an important effect on embryonic development and the offspring's health [16, 52] ; however, when the one-cell-stage embryo of diabetic mothers is transferred to nondiabetic pseudopregnant recipients, the malformation of embryos is still observed in the streptozotocininduced mouse model [53] . This finding suggests that embryo development is not the only susceptible period for the onset of metabolic diseases in the offspring from diabetic mothers. During oogenesis, the DNA methylation is erased and is then almost completely reestablished at the metaphase II stage [54] . The DNA methylation status of CpG islands in oocytes is a critical factor in determining methylation patterns in preimplantation embryos [55] . During oogenesis, the DNA methylation patterns are susceptible to being altered in oocytes. For example, the DNA methylation patterns are abnormal in oocytes of old mice [56] ; if the methyl donor levels are lower in the culture medium during mouse follicle culture, the DNA methylation status of oocytes is altered [57] . Postovulatory oocyte aging also induces abnormal DNA methylation in oocytes [58] .
Oocyte quality of diabetic females is compromised by the hyperglycemic environment. Communication between oocytes and cumulus cells is reduced due to the decreased expression of gap junction and connexin proteins [59] . The abnormal expression of the glucose transporters impairs glucose metabolism in oocytes, altering their metabolism [49, 60] . Glucose and pyruvate are crucial for nuclear and cytoplasmic maturation of oocytes [61, 62] . Establishing proper DNA methylation is an important event during nuclear maturation of oocytes, and the DNA remethylation process in oocytes is sensitive to the environment. Recently, we showed that female mice fed with high-fat diet after weaning had altered DNA methylation patterns of Leptin and Ppar-a in oocytes at 15 wk of age [63] . We also investigated the effects of maternal diabetes mellitus on DNA methylation patterns of imprinted genes in oocytes using a streptozotocin-induced diabetic mouse model and nonobese diabetic mouse model (NOD) [64] . In the following, we will give a brief summary of our findings.
By combined bisulfite restriction analysis (COBRA) and bisulfite sequencing (BS) [64] , we found that the DNA methylation patterns of Peg3 and Snrpn were not altered in MII oocytes of diabetic females on Day 15 and 25 after injection of streptozotocin. But on Day 35, the methylation status of Peg3 was significantly decreased in oocytes of diabetic females compared with oocytes of nondiabetic females. Similar results were obtained in NOD mice. This indicates that the DNA methylation pattern of Peg3 was altered by maternal diabetes mellitus in a time-dependent manner in these mouse models. We also evaluated the expression of DNA methyltransferases (DNMTs) in oocytes by real-time PCR. We found that the expression of DNMT1, DNMT3a, DNMT3b, and DNMT3l in oocytes of diabetic females, compared with the expression in oocytes of nondiabetic females, was also decreased in a time-dependent manner. DNA methylation reestablishment in oocytes is catalyzed mainly by DNMT3a and DNMT3b, which are coordinately regulated [65, 66] . In our study, we found that the decreased expression of DNMTs may cause the alterations of DNA methylation of Peg3. Ding et al. [67] reported that the histone acetylation in oocytes of mice was also changed by maternal diabetes.
At 15 days after injection of streptozotocin, we mated the female diabetic mice and/or nondiabetic mice with nondiabetic male mice and then evaluated the DNA methylation level of the imprinted genes in oocytes from offspring of diabetic and nondiabetic mothers by COBRA and BS. We found that the DNA methylation status of the analyzed imprinted genes was not changed. This coincided with the methylation patterns of oocytes from diabetic females. However, the genome-wide DNA methylation patterns in oocytes from offspring of diabetic mothers were still unclear because we analyzed only the DNA methylation patterns of H19, Peg3, and Snrpn in oocytes of offspring from diabetic mothers. It is also still unclear whether the DNA methylation patterns and histone modifications of other genes in oocytes are altered by maternal diabetes mellitus and whether the deleterious effects of maternal diabetes mellitus on offspring is transmitted to the next generations by germ cells.
EPIGENETICS IN OOCYTES/EMBRYOS OF DIABETIC MOTHERS
Overall, we revealed that the DNA methylation patterns of imprinted genes in oocytes were altered by maternal diabetes mellitus [64] . These data indicate that metabolic diseases in offspring from diabetic mothers may be initiated in oocytes (Table 1) .
UNDERLYING MECHANISMS: HYPERGLYCEMIA AND EPIGENETICS
As discussed above, the epigenetic modification of offspring may be altered by maternal diabetes mellitus, which may be a crucial reason for metabolic diseases in offspring from diseaseaffected mothers. Not only does the intrauterine hyperglycemic environment play a significant role in the alterations of epigenetic modifications in the development of disease [68] , but the hyperglycemic environment of maternal diabetes also has deleterious effects on the proper epigenetic establishment of oocytes [64] . Glucose is crucial for nuclear and cytoplasmic maturation of oocytes [61, 62] (Fig. 1) . Maternal hyperglycemia decreases de novo purine and cAMP synthesis and induces poor nuclear maturation of oocytes because the flux of glucose through the pentose phosphate pathway is decreased [69] . Although the flux of glucose through glycolysis was not affected [69] , the AMP:ATP ratio was increased in denuded oocytes from diabetic mice [70] . This indicates that intracellular ATP is rapidly used [70] . Wellen et al. [51] reported that ATP-citrate lysase was crucial for histone modification. Ding et al. [67] reported that the histone acetylation in oocytes of mice was changed by maternal diabetes. This indicates that the maternal hyperglycemia may be a crucial reason for the alteration of epigenetic modifications of oocytes. The mRNA expression profile of oocytes from diabetic mice was significantly affected compared to controls [71] . Many of the affected genes are included in the metabolism and epigenetic modifications [71] , so these may directly contribute to the abnormal establishment of epigenetics in oocytes from diabetic mice.
In cleavage-stage embryos, glucose is not the main fuel for many species until compaction and blastocyst formation. However, as in oocytes, glucose is crucial for DNA modification in early embryos [43, 44] . The changed expression of glucose transporters, such as GLUT1, 2, 3 [48] and MCT (H þ -monocarboxylate cotransporter) [72] , in early embryos exposed to a hyperglycemic condition may crucially contribute to the changed epigenetic modifications. The changed expression of epigenetic-associated genes in oocytes of diabetic mothers may be another reason for the changed histone modification of embryos exposed to the hyperglycemic environment [43] because the reserved proteins in oocytes are vital for early embryonic development [73] (Fig. 1) .
CONCLUSIONS AND PERSPECTIVES
From the above discussion, we conclude that the epigenetic alterations in offspring from maternal mothers may originate, in addition to the intrauterine environment, from oocytes and that the maternal hyperglycemic environment may be a main reason for the detrimental effects on epigenetics in oocytes and embryos. However, the detailed mechanism(s) causing the alteration of epigenetics are still not completely understood.
Although the DNA methylation and histone modification in oocytes and embryos are negatively affected by maternal diabetes mellitus, how maternal diabetes mellitus induces this detrimental effect on epigenetics is still incompletely understood. Hyperglycemia may not be the only factor because the risk of metabolic syndrome in adult offspring of women with controlled gestational diabetes mellitus or type 1 diabetes compared with adult offspring from the background population is increased 4-and 2.5-fold, respectively [7] . Therefore, discovering whether there are other factors included in causing epigenetic alterations in offspring of diabetic mothers is needed. The detailed underlying mechanism of how glucose causes the epigenetic changes is also poorly understood.
Offspring of severely and mildly hyperglycemic mothers (the second generation) developed gestational diabetes, and their offspring, the third generation, also displayed a similar metabolic syndrome as offspring of mildly hyperglycemic mothers [74, 75] . This indicates that the effects on offspring exposed to maternal diabetes can be transmitted to the next generations, but genetics alone cannot completely explain this phenomenon because the effect is induced by the interaction between genes and the environment. Epigenetic modifications are generally assumed to mediate gene-environment interactions, leading to persistent changes of gene regulation and metabolic pathways [22, 23] . However, how the alterations of epigenetics in offspring of maternal diabetes are transmitted to the next generations by oocytes is poorly understood. In humans, although the number of diabetic individuals is increasing rapidly, it is difficult to look for the mechanism(s) underlying the inheritance of detrimental effects on offspring exposed to maternal diabetes between generations. Therefore, we need to use appropriate animal models to investigate how GE ET AL. maternal diabetes transmits the changed epigenetic modifications to the next generations.
